Correlation Between Lien Chang and GeneReach Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lien Chang and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lien Chang and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lien Chang Electronic and GeneReach Biotechnology, you can compare the effects of market volatilities on Lien Chang and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lien Chang with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lien Chang and GeneReach Biotechnology.

Diversification Opportunities for Lien Chang and GeneReach Biotechnology

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lien and GeneReach is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lien Chang Electronic and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Lien Chang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lien Chang Electronic are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Lien Chang i.e., Lien Chang and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Lien Chang and GeneReach Biotechnology

Assuming the 90 days trading horizon Lien Chang Electronic is expected to generate 3.5 times more return on investment than GeneReach Biotechnology. However, Lien Chang is 3.5 times more volatile than GeneReach Biotechnology. It trades about 0.01 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.23 per unit of risk. If you would invest  1,400  in Lien Chang Electronic on September 15, 2024 and sell it today you would lose (20.00) from holding Lien Chang Electronic or give up 1.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lien Chang Electronic  vs.  GeneReach Biotechnology

 Performance 
       Timeline  
Lien Chang Electronic 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lien Chang Electronic are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Lien Chang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
GeneReach Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Lien Chang and GeneReach Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lien Chang and GeneReach Biotechnology

The main advantage of trading using opposite Lien Chang and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lien Chang position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.
The idea behind Lien Chang Electronic and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data